Connect with us

Hi, what are you looking for?

Jewish Business News

Court

Teva Settles Viagra Patent Litigation With Pfizer


Teva says it will be able to launch generic Viagra in the US in 2017.

viagra teva law

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that its subsidiary Teva Pharmaceuticals USA, Inc. has entered into an agreement with Pfizer Inc. to settle patent litigation related to Teva’s generic version of Pfizer’s Viagra (sildenafil citrate) tablets.

Under the terms of the agreement Teva will be able to launch its Abbreviated New Drug Application (ANDA) products pursuant to a royalty-bearing license on December 11, 2017, or earlier under certain circumstances. The terms of the settlement agreement are otherwise confidential.

The U.S. Food and Drug Administration (FDA) has already granted tentative approval for Teva’s generic version of Pfizer’s Viagra (sildenafil citrate) tablets, 25, 50, and 100 mg.

Viagra had annual sales of approximately $1.2 billion in the United States, based on IMS sales data as of September 2013.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

Business

Now Platika joins and elite club of $10 billion plus Israeli firms.

Advertisement
cialis